These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 6753446)
1. Femoxetine in the prophylaxis of migraine--a randomised comparison with placebo. Zeeberg I; Orholm M; Nielsen JD; Honore PL; Larsen JJ Acta Neurol Scand; 1981 Dec; 64(6):452-9. PubMed ID: 6753446 [TBL] [Abstract][Full Text] [Related]
2. Propranolol and femoxetine, a HT-uptake inhibitor, in migraine prophylaxis. A double-blind crossover study. Andersson PG; Petersen EN Acta Neurol Scand; 1981 Oct; 64(4):280-8. PubMed ID: 7032183 [TBL] [Abstract][Full Text] [Related]
3. Femoxetine - a new 5-HT uptake inhibitor - and propranolol in the prophylactic treatment of migraine. Kangasniemi PJ; Nyrke T; Lang AH; Petersen E Acta Neurol Scand; 1983 Oct; 68(4):262-7. PubMed ID: 6606930 [TBL] [Abstract][Full Text] [Related]
4. A randomized general practice group-comparative study of femoxetine and placebo in the prophylaxis of migraine. Orholm M; Honoré PF; Zeeberg I Acta Neurol Scand; 1986 Sep; 74(3):235-9. PubMed ID: 3538753 [TBL] [Abstract][Full Text] [Related]
5. So-called "tension headache"--the response to a 5-HT uptake inhibitor: femoxetine. Sjaastad O Cephalalgia; 1983 Mar; 3(1):53-60. PubMed ID: 6850822 [TBL] [Abstract][Full Text] [Related]
6. The treatment of accessory symptoms in narcolepsy: a double-blind cross-over study of a selective serotonin re-uptake inhibitor (femoxetine) versus placebo. Schrader H; Kayed K; Bendixen Markset AC; Treidene HE Acta Neurol Scand; 1986 Oct; 74(4):297-303. PubMed ID: 3544654 [TBL] [Abstract][Full Text] [Related]
7. Femoxetine in the treatment of obese patients in general practice. A randomized group comparative study with placebo. Bitsch M; Skrumsager BK Int J Obes; 1987; 11(2):183-90. PubMed ID: 3301710 [TBL] [Abstract][Full Text] [Related]
8. Changes in platelet function and blood serotonin level in migraine patients during treatment with femoxetine. Dalsgaard-Nielsen J; le Fèvre Honoré P; Zeeberg I Acta Neurol Scand; 1982 Aug; 66(2):191-8. PubMed ID: 6982585 [TBL] [Abstract][Full Text] [Related]
9. Femoxetine and amitriptyline in general practice: a randomized double-blind group comparison. Skrumsager BK; Jeppesen K Pharmacopsychiatry; 1986 Sep; 19(5):368-77. PubMed ID: 3774871 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerance of femoxetine and imipramine in the treatment of depressive states. A randomized, double-blind study. Suominen J; Tamminen T; Elosuo R; Manniche PM Pharmacopsychiatry; 1988 Sep; 21(5):238-44. PubMed ID: 3067246 [TBL] [Abstract][Full Text] [Related]
11. Reduction of whole blood serotonin in depressed patients treated with a new, selective serotonin-uptake inhibitor, femoxetine. Børup C; Petersen IM; le Fèvre Honoré P; Wetterberg L Psychopharmacology (Berl); 1979 Jun; 63(3):241-3. PubMed ID: 113809 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies. Mannix LK; Savani N; Landy S; Valade D; Shackelford S; Ames MH; Jones MW Headache; 2007; 47(7):1037-49. PubMed ID: 17635595 [TBL] [Abstract][Full Text] [Related]
13. A controlled double-blind study of femoxetine and amitriptyline in patients with endogenous depression. Reebye PN; Yiptong C; Samsoon J; Schulsinger F; Fabricius J Pharmacopsychiatria; 1982 Sep; 15(5):164-9. PubMed ID: 6757983 [TBL] [Abstract][Full Text] [Related]
14. Cimetidine in the prophylaxis of migraine. Nanda RN; Arthur GP; Johnson RH; Lambie DG Acta Neurol Scand; 1980 Aug; 62(2):90-5. PubMed ID: 7010874 [TBL] [Abstract][Full Text] [Related]
15. Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial. Tfelt-Hansen P; Standnes B; Kangasneimi P; Hakkarainen H; Olesen J Acta Neurol Scand; 1984 Jan; 69(1):1-8. PubMed ID: 6367336 [TBL] [Abstract][Full Text] [Related]
16. Clonidine in the prophylaxis of migraine. Boisen E; Deth S; Hübbe P; Jansen J; Klee A; Leunbach G Acta Neurol Scand; 1978 Nov; 58(5):288-95. PubMed ID: 367043 [TBL] [Abstract][Full Text] [Related]
17. Steady-state visual evoked potentials during migraine prophylaxis by propranolol and femoxetine. Nyrke T; Kangasniemi P; Lang AH; Petersen E Acta Neurol Scand; 1984 Jan; 69(1):9-14. PubMed ID: 6608203 [TBL] [Abstract][Full Text] [Related]
18. Cardiovascular (ECG and systolic time intervals) and anticholinergic effects of repeated doses of femoxetine--a comparison with amitriptyline and placebo in healthy men. Warrington SJ; Turner P; Skrumsager BK Br J Clin Pharmacol; 1989 Mar; 27(3):343-51. PubMed ID: 2719894 [TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study. Dodick DW; Goadsby PJ; Spierings EL; Scherer JC; Sweeney SP; Grayzel DS Lancet Neurol; 2014 Sep; 13(9):885-92. PubMed ID: 25127173 [TBL] [Abstract][Full Text] [Related]